pubmed-article:7905722 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0043474 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0012133 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0220912 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0868945 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0220913 | lld:lifeskim |
pubmed-article:7905722 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:7905722 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:7905722 | pubmed:dateCreated | 1994-3-4 | lld:pubmed |
pubmed-article:7905722 | pubmed:abstractText | To determine the benefits of switching to didanosine compared with continuing zidovudine among patients infected with human immunodeficiency virus (HIV) who have previously used zidovudine and have signs of clinical deterioration. | lld:pubmed |
pubmed-article:7905722 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7905722 | pubmed:language | eng | lld:pubmed |
pubmed-article:7905722 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7905722 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:7905722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7905722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7905722 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7905722 | pubmed:month | Mar | lld:pubmed |
pubmed-article:7905722 | pubmed:issn | 0003-4819 | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:GreenS LSL | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:FrankII | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:ThompsonMM | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:BrandJJ | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:RiouGG | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:SpruanceS LSL | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:SweetD EDE | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:PetersonE AEA | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:PollardRR | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:Ramirez-Ronda... | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:BrownM JMJ | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:PetersonDD | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:DunkleL MLM | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:CrossAA | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:BerryAA | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:GugliottiRR | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:CraneLL | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:MacArthurR... | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:RemickS CSC | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:PaviaA TAT | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:SmaldoneLL | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:BernsteinB... | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:PattersonT... | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:PachuckiC TCT | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:Schindzielorz... | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:MoreyG EGE | lld:pubmed |
pubmed-article:7905722 | pubmed:author | pubmed-author:IngrahamPP | lld:pubmed |
pubmed-article:7905722 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7905722 | pubmed:day | 1 | lld:pubmed |
pubmed-article:7905722 | pubmed:volume | 120 | lld:pubmed |
pubmed-article:7905722 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7905722 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7905722 | pubmed:pagination | 360-8 | lld:pubmed |
pubmed-article:7905722 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:meshHeading | pubmed-meshheading:7905722-... | lld:pubmed |
pubmed-article:7905722 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7905722 | pubmed:articleTitle | Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. | lld:pubmed |
pubmed-article:7905722 | pubmed:affiliation | Holy Cross Hospital, Salt Lake City, Utah. | lld:pubmed |
pubmed-article:7905722 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7905722 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7905722 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:7905722 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:7905722 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:7905722 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7905722 | lld:pubmed |